The new chairman of the Advanced Medical Technology Association’s (AdvaMed’s) board of directors, Kevin Lobo, says the most pressing issue facing the industry is the Affordable Care Act’s 2.3 percent excise tax on medical devices, the latest moratorium on which ends next year. During a press call on Friday (April 5), Lobo said the lobby will work on several initiatives over his two-year tenure, but the device tax is the most current and pressing. Lobo, who succeeds CVRx President and...